Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected

The summary for the Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention ERA, which is the U.S. government agency offering this grant.

Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected: The purpose of this notice of funding opportunity is to support formative research on cis-gender Black women with HIV (CgBWH) and their acceptance and perceived barriers and facilitators of using current and future long-acting antiretroviral therapies. Use of a qualitative research design is expected to yield details and nuances of decision-making and circumstances related to uptake of Long-Acting Antiretroviral Therapies (LA-ART) that may not be possible to gather through quantitative data collection methods alone. This exploratory qualitative approach will offer a unique source of information about LA-ART from the perspectives and experiences of CgBWH, including barriers and facilitators to uptake and use and individual and systemic supports needed to facilitate delivery of this therapy. The findings of this research are expected to strengthen adherence to ART for this population and impact the racial/ethnic disparities in viral suppression observed for this group.

Federal Grant Title:	Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected
Federal Agency Name:	Centers for Disease Control and Prevention ERA (HHS-CDC-HHSCDCERA)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-PS-23-003
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.084
CFDA Descriptions:	Information not provided
Current Application Deadline:	March 17th, 2023
Original Application Deadline:	March 17th, 2023
Posted Date:	January 12th, 2023
Creation Date:	January 12th, 2023
Archive Date:	April 27th, 2023
Total Program Funding:	$1,000,000
Maximum Federal Grant Award:	$333,000
Minimum Federal Grant Award:	$300,000
Expected Number of Awards:	1
Cost Sharing or Matching:	No
Last Updated:	January 13th, 2023

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses
Additional Information on Eligibility: N/A
Grant Announcement Contact: Jocelyn Patterson Mosley
[email protected]
[email protected]
Similar Government Grants: • NCHHSTP Epidemiologic and Economic Modeling for HIV, Viral Hepatitis, STD, and TB; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...; • Improving the Quality of Life of People with HIV Aged 50 Years and Older in the United Sta...; • Understanding Infant Feeding Preferences, Practices, and Outcomes for Mothers and other Pa...; • PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...; • Impact of Japanese Encephalitis Vaccination in Cambodia; • Clinical, Epidemiologic and Ecologic Factors Impacting the Burden and Distribution of Monk...; • Reduction of Malaria in U.S. Residents Returning from Overseas Travel to Malaria-Endemic C...
More Grants from the Centers for Disease Control and Prevention ERA: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Advancing Public Health Research in Bangladesh; • Demonstration Projects to Research and Evaluate Strategies Aligned with CDC's What Works i...; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • A Bridge to Adherence: Long-Acting Antiretroviral Therapy for People with HIV Released fro...